financetom
Business
financetom
/
Business
/
Orezone Gold Second-Quarter Adjusted Earnings Double
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Orezone Gold Second-Quarter Adjusted Earnings Double
Aug 12, 2026 2:08 PM

04:48 PM EDT, 08/12/2026 (MT Newswires) -- Orezone Gold ( ORZCF ) said Wednesday after trade its second-quarter adjusted earnings doubled to $0.08 per share, from $0.04 per share.

The result missed the consensus analyst forecast of $0.10 per share, according to FactSet.

Orezone generated record revenue of $271.6 million, a 187% year over year increase, and above the $258 million expected.

The company reported record quarterly gold production of 58,566 ounces, compared with 27,548 ounces in the second quarter of last year. Gold sales totaled 60,654 ounces at an average realized price of $4,401 per ounce.

The record gold production was due to Casa Beradi's contribution, a statement said.

"The second quarter marked an important milestone for Orezone with our first full quarter as a two-mine gold producer following the acquisition of Casa Berardi. Both operations performed in line with expectations, delivering strong financial results and robust cash flow. At Bombore, we continued advancing the Stage 2A hard rock expansion, while at Casa Berardi, we continued laying the foundation for long-term value through operational improvements, underground development, and exploration," said Chief Executive Patrick Downey.

Orezone Gold ( ORZCF ) will release the Casa Berardi Life-of-Mine Study in September.

Orezone Gold ( ORZCF ) shares edged down C$0.01 to C$2.65 on the Toronto Stock Exchange.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
U.S. FDA approves ImmunityBio's bladder cancer therapy
U.S. FDA approves ImmunityBio's bladder cancer therapy
Apr 22, 2024
April 22 (Reuters) - The U.S. FDA approved ImmunityBio's ( IBRX ) combination therapy to treat a type of bladder cancer, the regulator said on Monday, which would help bring the company's first product to market. ...
ADM CFO to resign as company faces US government investigation
ADM CFO to resign as company faces US government investigation
Apr 22, 2024
(Reuters) - Grain trader Archer-Daniels-Midland ( ADM ) said on Monday that Chief Financial Officer Vikram Luthar will resign from his role effective Sept. 30. Luthar is the highest-level executive to leave the firm since it disclosed accounting issues within its Nutrition division that later triggered two government investigations and forced it to revise six years of financial data. ADM...
Copper output at Chile's Codelco set to rise this year, CESCO says
Copper output at Chile's Codelco set to rise this year, CESCO says
Apr 22, 2024
SANTIAGO (Reuters) - Chile's state-run copper miner Codelco is poised to improve production this year and begin to climb from its lowest dip in a quarter century, the head of Chilean copper studies center CESCO said ahead of a major industry conference that starts Monday. Codelco is aiming to produce between 1.325 million and 1.390 million metric tons of copper...
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Clearwater Analytics Completes Acquisition of Risk and Performance Analytics Solutions From Wilshire
Apr 22, 2024
06:00 PM EDT, 04/22/2024 (MT Newswires) -- Clearwater Analytics ( CWAN ) said Monday it completed the acquisition of risk and performance analytics products from Wilshire Advisors. Wilshire Axiom, Wilshire Atlas, Wilshire Abacus and Wilshire iQComposite will be integrated with Clearwater's offerings. Clearwater previously said the assets will cost $40 million and add about $7 million in annualized revenue. ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved